Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Operating Income (2016 - 2026)

Phibro Animal Health has reported Operating Income over the past 14 years, most recently at $50.3 million for Q4 2025.

  • For Q4 2025, Operating Income rose 97.1% year-over-year to $50.3 million; the TTM value through Dec 2025 reached $168.8 million, up 106.96%, while the annual FY2025 figure was $110.5 million, 107.19% up from the prior year.
  • Operating Income for Q4 2025 was $50.3 million at Phibro Animal Health, down from $51.3 million in the prior quarter.
  • Over five years, Operating Income peaked at $51.3 million in Q3 2025 and troughed at -$726000.0 in Q3 2023.
  • A 5-year average of $22.8 million and a median of $19.6 million in 2022 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: crashed 105.31% in 2023 and later surged 2537.88% in 2024.
  • Year by year, Operating Income stood at $22.3 million in 2021, then decreased by 28.93% to $15.8 million in 2022, then dropped by 0.9% to $15.7 million in 2023, then soared by 62.62% to $25.5 million in 2024, then skyrocketed by 97.1% to $50.3 million in 2025.
  • Business Quant data shows Operating Income for PAHC at $50.3 million in Q4 2025, $51.3 million in Q3 2025, and $33.7 million in Q2 2025.